Review



fecal samples from tobramycin rats  (BASF)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BASF fecal samples from tobramycin rats
    Intrinsic fecal bile acid composition and changes (A–I) over time (0 h, 4 h, 8 h, 24 h) in in vitro anaerobic rat fecal incubations with or without (control) treatment with the antibiotics colistin sulfate and <t>tobramycin</t> (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations
    Fecal Samples From Tobramycin Rats, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fecal+samples+from+tobramycin+rats/pmc09584874-46-4-9?v=BASF
    Average 90 stars, based on 1 article reviews
    fecal samples from tobramycin rats - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "In vitro models to detect in vivo bile acid changes induced by antibiotics"

    Article Title: In vitro models to detect in vivo bile acid changes induced by antibiotics

    Journal: Archives of Toxicology

    doi: 10.1007/s00204-022-03373-4

    Intrinsic fecal bile acid composition and changes (A–I) over time (0 h, 4 h, 8 h, 24 h) in in vitro anaerobic rat fecal incubations with or without (control) treatment with the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations
    Figure Legend Snippet: Intrinsic fecal bile acid composition and changes (A–I) over time (0 h, 4 h, 8 h, 24 h) in in vitro anaerobic rat fecal incubations with or without (control) treatment with the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Techniques Used: In Vitro, Control

    Time-dependent deconjugation of taurine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations
    Figure Legend Snippet: Time-dependent deconjugation of taurine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Techniques Used: In Vitro, Control

    Time-dependent deconjugation of glycine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations
    Figure Legend Snippet: Time-dependent deconjugation of glycine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Techniques Used: In Vitro, Control

    Time-dependent deconjugation of TCA ( A ) and formation of its metabolite CA ( B ) in in vitro anaerobic incubations with fecal samples from rats exposed for 23 days to 0 (control) or 1000 mg/kg bw/day tobramycin in vivo (* P < 0.05, ** P < 0.01, **** P < 0.0001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations
    Figure Legend Snippet: Time-dependent deconjugation of TCA ( A ) and formation of its metabolite CA ( B ) in in vitro anaerobic incubations with fecal samples from rats exposed for 23 days to 0 (control) or 1000 mg/kg bw/day tobramycin in vivo (* P < 0.05, ** P < 0.01, **** P < 0.0001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Techniques Used: In Vitro, Control, In Vivo

    Time-dependent translocation of TCA across a Caco-2 cell layer upon pre-exposure with 45 mM tobramycin or without tobramycin (control) (* P < 0.05 indicates a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from four independent experiments
    Figure Legend Snippet: Time-dependent translocation of TCA across a Caco-2 cell layer upon pre-exposure with 45 mM tobramycin or without tobramycin (control) (* P < 0.05 indicates a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from four independent experiments

    Techniques Used: Translocation Assay, Control



    Similar Products

    fecal samples from tobramycin rats  (BASF)
    90
    BASF fecal samples from tobramycin rats
    Intrinsic fecal bile acid composition and changes (A–I) over time (0 h, 4 h, 8 h, 24 h) in in vitro anaerobic rat fecal incubations with or without (control) treatment with the antibiotics colistin sulfate and <t>tobramycin</t> (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations
    Fecal Samples From Tobramycin Rats, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fecal+samples+from+tobramycin+rats/pmc09584874-46-4-9?v=BASF
    Average 90 stars, based on 1 article reviews
    fecal samples from tobramycin rats - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Intrinsic fecal bile acid composition and changes (A–I) over time (0 h, 4 h, 8 h, 24 h) in in vitro anaerobic rat fecal incubations with or without (control) treatment with the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Journal: Archives of Toxicology

    Article Title: In vitro models to detect in vivo bile acid changes induced by antibiotics

    doi: 10.1007/s00204-022-03373-4

    Figure Lengend Snippet: Intrinsic fecal bile acid composition and changes (A–I) over time (0 h, 4 h, 8 h, 24 h) in in vitro anaerobic rat fecal incubations with or without (control) treatment with the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Article Snippet: The fecal samples from tobramycin rats were provided by BASF and taken from an in vivo study in which Wistar rats were orally administrated a series of antibiotics, including tobramycin, for 28 days.

    Techniques: In Vitro, Control

    Time-dependent deconjugation of taurine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Journal: Archives of Toxicology

    Article Title: In vitro models to detect in vivo bile acid changes induced by antibiotics

    doi: 10.1007/s00204-022-03373-4

    Figure Lengend Snippet: Time-dependent deconjugation of taurine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Article Snippet: The fecal samples from tobramycin rats were provided by BASF and taken from an in vivo study in which Wistar rats were orally administrated a series of antibiotics, including tobramycin, for 28 days.

    Techniques: In Vitro, Control

    Time-dependent deconjugation of glycine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Journal: Archives of Toxicology

    Article Title: In vitro models to detect in vivo bile acid changes induced by antibiotics

    doi: 10.1007/s00204-022-03373-4

    Figure Lengend Snippet: Time-dependent deconjugation of glycine conjugated bile acids to their deconjugated metabolites in in vitro anaerobic rat fecal incubations (A–D) in the absence (control) and presence of the antibiotics colistin sulfate and tobramycin (* P < 0.05, ** P < 0.01, *** P < 0.001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Article Snippet: The fecal samples from tobramycin rats were provided by BASF and taken from an in vivo study in which Wistar rats were orally administrated a series of antibiotics, including tobramycin, for 28 days.

    Techniques: In Vitro, Control

    Time-dependent deconjugation of TCA ( A ) and formation of its metabolite CA ( B ) in in vitro anaerobic incubations with fecal samples from rats exposed for 23 days to 0 (control) or 1000 mg/kg bw/day tobramycin in vivo (* P < 0.05, ** P < 0.01, **** P < 0.0001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Journal: Archives of Toxicology

    Article Title: In vitro models to detect in vivo bile acid changes induced by antibiotics

    doi: 10.1007/s00204-022-03373-4

    Figure Lengend Snippet: Time-dependent deconjugation of TCA ( A ) and formation of its metabolite CA ( B ) in in vitro anaerobic incubations with fecal samples from rats exposed for 23 days to 0 (control) or 1000 mg/kg bw/day tobramycin in vivo (* P < 0.05, ** P < 0.01, **** P < 0.0001 indicate a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from three independent incubations

    Article Snippet: The fecal samples from tobramycin rats were provided by BASF and taken from an in vivo study in which Wistar rats were orally administrated a series of antibiotics, including tobramycin, for 28 days.

    Techniques: In Vitro, Control, In Vivo

    Time-dependent translocation of TCA across a Caco-2 cell layer upon pre-exposure with 45 mM tobramycin or without tobramycin (control) (* P < 0.05 indicates a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from four independent experiments

    Journal: Archives of Toxicology

    Article Title: In vitro models to detect in vivo bile acid changes induced by antibiotics

    doi: 10.1007/s00204-022-03373-4

    Figure Lengend Snippet: Time-dependent translocation of TCA across a Caco-2 cell layer upon pre-exposure with 45 mM tobramycin or without tobramycin (control) (* P < 0.05 indicates a difference from the control without antibiotic at the corresponding time point). Results are shown as mean ± SD from four independent experiments

    Article Snippet: The fecal samples from tobramycin rats were provided by BASF and taken from an in vivo study in which Wistar rats were orally administrated a series of antibiotics, including tobramycin, for 28 days.

    Techniques: Translocation Assay, Control